ENTRY       D01205                      Drug
NAME        Dexmedetomidine hydrochloride (JAN/USP);
            Igalmi (TN);
            Precedex (TN)
PRODUCT     DEXMEDETOMIDINE HYDROCHLORIDE (WG Critical Care)
            IGALMI (BioXcel Therapeutics)
            PRECEDEX (Henry Schein)
            PRECEDEX (Hospira)
            PRECEDEX (Hospira)
            PRECEDEX (Hospira)
  GENERIC   DEXMEDETOMIDINE (Accord Healthcare)
            DEXMEDETOMIDINE (Accord Healthcare)
            DEXMEDETOMIDINE (Akorn)
            DEXMEDETOMIDINE (Athenex Pharmaceutical Division)
            DEXMEDETOMIDINE (Eugia US LLC)
            DEXMEDETOMIDINE (Gland Pharma Limited)
            DEXMEDETOMIDINE (Medical Purchasing Solutions)
            DEXMEDETOMIDINE (Meitheal Pharmaceuticals)
            DEXMEDETOMIDINE (Mylan Institutional LLC)
            DEXMEDETOMIDINE (Piramal Critical Care)
            DEXMEDETOMIDINE (Piramal Critical Care)
            DEXMEDETOMIDINE (Piramal Critical Care)
            DEXMEDETOMIDINE HCL (Hikma Pharmaceuticals USA)
            DEXMEDETOMIDINE HCL (Medical Purchasing Solutions)
            DEXMEDETOMIDINE HYDROCHLORIDE (Amneal Pharmaceuticals LLC)
            DEXMEDETOMIDINE HYDROCHLORIDE (Amneal Pharmaceuticals LLC)
            DEXMEDETOMIDINE HYDROCHLORIDE (Baxter Healthcare Company)
            DEXMEDETOMIDINE HYDROCHLORIDE (Baxter Healthcare Corporation)
            DEXMEDETOMIDINE HYDROCHLORIDE (CIVICA)
            DEXMEDETOMIDINE HYDROCHLORIDE (Dr.Reddy's Laboratories)
            DEXMEDETOMIDINE HYDROCHLORIDE (Fresenius Kabi USA)
            DEXMEDETOMIDINE HYDROCHLORIDE (Fresenius Kabi USA)
            DEXMEDETOMIDINE HYDROCHLORIDE (Gland Pharma Limited)
            DEXMEDETOMIDINE HYDROCHLORIDE (Hikma Pharmaceuticals USA)
            DEXMEDETOMIDINE HYDROCHLORIDE (Medical Purchasing Solutions)
            DEXMEDETOMIDINE HYDROCHLORIDE (Medical Purchasing Solutions)
            DEXMEDETOMIDINE HYDROCHLORIDE (Medical Purchasing Solutions)
            DEXMEDETOMIDINE HYDROCHLORIDE (Mylan Institutional LLC)
            DEXMEDETOMIDINE HYDROCHLORIDE (Par Pharmaceutical)
            DEXMEDETOMIDINE HYDROCHLORIDE (Piramal Critical Care)
            DEXMEDETOMIDINE HYDROCHLORIDE (Slayback Pharma LLC)
            DEXMEDETOMIDINE HYDROCHLORIDE (Slayback Pharma LLC)
            DEXMEDETOMIDINE HYDROCHLORIDE (Sun Pharmaceuticals Industries)
            DEXMEDETOMIDINE HYDROCHLORIDE (Zydus Lifesciences Limited)
            DEXMEDETOMIDINE HYDROCHLORIDE (Zydus Pharmaceuticals USA)
            DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE (Baxter Healthcare Corporation)
            DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE (Sandoz)
            DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE (Precision Dose)
            DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE (TAGI Pharma)
FORMULA     C13H16N2. HCl
EXACT_MASS  236.108
MOL_WEIGHT  236.7405
CLASS       Cardiovascular agent
             DG01456  Adrenergic receptor agonist
              DG01450  alpha-Adrenergic receptor agonist
               DG01449  alpha2-Adrenergic receptor agonist
            Metabolizing enzyme substrate
             DG01892  CYP1A2 substrate
             DG01638  CYP2A6 substrate
             DG01639  CYP2C19 substrate
             DG01644  CYP2D6 substrate
             DG02855  CYP2E1 substrate
REMARK      Therapeutic category: 1129
            ATC code: N05CM18
            Chemical structure group: DG00926
            Product (DG00926): D01205<JP/US>
EFFICACY    Sedative-hypnotic, Tranquilizer, alpha2-Adrenergic receptor agonist
  DISEASE   Schizophrenia [DS:H01649]
            Bipolar I or II disorder [DS:H01653]
TARGET      ADRA2 [HSA:150 151 152] [KO:K04138 K04139 K04140]
  PATHWAY   hsa04080(150+151+152)  Neuroactive ligand-receptor interaction
METABOLISM  Enzyme: CYP2A6 [HSA:1548]; CYP1A2 [HSA:1544], CYP2E1 [HSA:1571], CYP2D6 [HSA:1565], CYP2C19 [HSA:1557]
INTERACTION  
STR_MAP     map07215  alpha-Adrenergic receptor agonists/antagonists
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N05 PSYCHOLEPTICS
               N05C HYPNOTICS AND SEDATIVES
                N05CM Other hypnotics and sedatives
                 N05CM18 Dexmedetomidine
                  D01205  Dexmedetomidine hydrochloride (JAN/USP) &lt;JP/US&gt;
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              11  Agents affecting central nervous system
               112  Hypnotics and sedatives, anxiolytics
                1129  Others
                 D01205  Dexmedetomidine hydrochloride (JAN/USP)
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01456  Adrenergic receptor agonist
               DG01450  alpha-Adrenergic receptor agonist
                DG01449  alpha2-Adrenergic receptor agonist
                 DG00926  Dexmedetomidine
                  D01205  Dexmedetomidine hydrochloride
             Metabolizing enzyme substrate
              DG01892  CYP1A2 substrate
               DG00926  Dexmedetomidine
                D01205  Dexmedetomidine hydrochloride
              DG01638  CYP2A6 substrate
               DG00926  Dexmedetomidine
                D01205  Dexmedetomidine hydrochloride
              DG01639  CYP2C19 substrate
               DG00926  Dexmedetomidine
                D01205  Dexmedetomidine hydrochloride
              DG01644  CYP2D6 substrate
               DG00926  Dexmedetomidine
                D01205  Dexmedetomidine hydrochloride
              DG02855  CYP2E1 substrate
               DG00926  Dexmedetomidine
                D01205  Dexmedetomidine hydrochloride
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Adrenaline
                ADRA2
                 D01205  Dexmedetomidine hydrochloride (JAN/USP) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D01205
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D01205
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D01205
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D01205
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D01205
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01456  Adrenergic receptor agonist
               DG01450  alpha-Adrenergic receptor agonist
                DG01449  alpha2-Adrenergic receptor agonist
                 DG00926  Dexmedetomidine
             Metabolizing enzyme substrate
              DG01892  CYP1A2 substrate
               DG00926  Dexmedetomidine
              DG01638  CYP2A6 substrate
               DG00926  Dexmedetomidine
              DG01639  CYP2C19 substrate
               DG00926  Dexmedetomidine
              DG01644  CYP2D6 substrate
               DG00926  Dexmedetomidine
              DG02855  CYP2E1 substrate
               DG00926  Dexmedetomidine
DBLINKS     CAS: 145108-58-3
            PubChem: 7848268
            ChEBI: 31472
            LigandBox: D01205
ATOM        16
            1   X   Cl   27.3320  -22.4150
            2   C8y C    20.8462  -21.6678
            3   C1c C    22.0574  -20.9599
            4   C8y C    19.6349  -20.9599
            5   C8x C    20.8462  -23.0602
            6   C8y C    23.2859  -21.6678
            7   C1a C    22.0574  -19.5614
            8   C8y C    18.4180  -21.6678
            9   C1a C    19.6292  -19.5614
            10  C8x C    19.6349  -23.7624
            11  C8x C    23.3213  -23.0709
            12  N5x N    24.5990  -21.1978
            13  C8x C    18.4238  -23.0719
            14  C1a C    17.2070  -20.9657
            15  N4x N    24.6642  -23.4622
            16  C8x C    25.4403  -22.3076
BOND        16
            1     2   3 1
            2     2   4 2
            3     2   5 1
            4     3   6 1
            5     3   7 1 #Down
            6     4   8 1
            7     4   9 1
            8     5  10 2
            9     6  11 2
            10    6  12 1
            11    8  13 2
            12    8  14 1
            13   11  15 1
            14   12  16 2
            15   10  13 1
            16   15  16 1
///
